Zogenix, Inc(NASDAQ:ZGNX) 
Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials...
Website: http://www.zogenix.com
Full Time Employees: 218 (May 2021)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2021-09-09
P
O 14.88
H 15.46
L 14.83
C 15.18
V 687,782
10EMA 15.18
20EMA 15.18
60EMA 15.18
120EMA 15.18
250EMA 15.18